Tyrosine Kinase Inhibitors PI3 Kinase Inhibitors Epigenetics CD Protein Inhibitors Immune Checkpoint Inhibitors Immunotherapy | Diffuse Large B Cell Lymphoma | Colorectal Cancer | HER2 Positive Breast Cancer | Triple Negative Breast Cancer |
---|---|---|---|---|
CUDC-907 | ||||
regorafenib | ||||
trastuzumab + atezolizumab + pertuzumab | ||||
Immunotherapy | ||||
R-CHOP |